title: Loss of heterozygosis on IFN-alpha locus is a prognostic indicator of bacillus Calmette-Guerin response for nonmuscle invasive bladder cancer.
authors.affiliation: Department of Urology, University of Florence, Florence, Italy. ktommy@libero.it
authors.forename: Tommaso
authors.initials: T
authors.lastname: Cai
authors.forename: Gabriella
authors.initials: G
authors.lastname: Nesi
authors.forename: Maurizio
authors.initials: M
authors.lastname: Dal Canto
authors.forename: Galliano
authors.initials: G
authors.lastname: Tinacci
authors.forename: Nicola
authors.initials: N
authors.lastname: Mondaini
authors.forename: Mauro
authors.initials: M
authors.lastname: Piazzini
authors.forename: Pierangelo
authors.initials: P
authors.lastname: Geppetti
authors.forename: Riccardo
authors.initials: R
authors.lastname: Bartoletti
mesh_terms: D000283:Administration, Intravesical; D000368:Aged; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005838:Genotype; D006801:Humans; D016898:Interferon-alpha / Q000235:genetics*; D019656:Loss of Heterozygosity; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D016133:Polymerase Chain Reaction; D011379:Prognosis; D016016:Proportional Hazards Models; D011446:Prospective Studies; D012307:Risk Factors; D018709:Statistics, Nonparametric; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology / Q000601:surgery
chemical_list: D001500:BCG Vaccine; D016898:Interferon-alpha